Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents (Q31064047)

24 September 2017

Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents (English)

1 reference

24 September 2017

1 reference

4

John D Morrey

1 reference

24 September 2017

Radhakrishnan P Iyer

1

1 reference

24 September 2017

Yi Jin

2

1 reference

24 September 2017

Arlene Roland

3

1 reference

24 September 2017

Samir Mounir

5

1 reference

24 September 2017

Brent Korba

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Antimicrobial Agents and Chemotherapy

24 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 September 2017

48

1 reference

24 September 2017

6

1 reference

24 September 2017

2199-2205

1 reference

Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

HIV integrase as a target for antiviral chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Parallel solid-phase synthesis of nucleoside phosphoramidate libraries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Antiviral L-nucleosides specific for hepatitis B virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Synthesis and antiviral evaluation of nucleic acid-based (NAB) libraries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Target-oriented and diversity-oriented organic synthesis in drug discovery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

In vitro evaluation of combination therapies against hepatitis B virus replication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

A cell culture assay for compounds which inhibit hepatitis B virus replication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415564

10.1128/AAC.48.6.2199-2205.2004

25 November 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

24 September 2017

1 reference